Loading...
Market
Quartet Nanocage Vaccine Efficacy Over 75% by Mid-2025?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Published results from phase 3 clinical trials
Story
Cambridge Uni's 'Quartet Nanocage' Vaccine Targets All Coronaviruses
May 6, 2024, 03:25 PM
Researchers at Cambridge University have developed a groundbreaking vaccine technology, known as proactive vaccinology, which offers protection against a wide range of coronaviruses, including those not yet discovered. This new approach utilizes a 'quartet nanocage' structure to build immunity against potential future pathogens. The vaccine has shown effectiveness in mice and is designed to preemptively combat the threats of upcoming pandemics.
View original story
Similar markets
Pre-clinical • 25%
Phase 1 • 25%
Phase 2 • 25%
Phase 3 • 25%
Under 50% effective • 33%
50-75% effective • 33%
Over 75% effective • 33%
USA • 25%
UK • 25%
China • 25%
Canada • 25%
Below 50% effective • 25%
50%-70% effective • 25%
71%-90% effective • 25%
More than 90% effective • 25%
Highly effective • 33%
Moderately effective • 33%
Ineffective • 34%